Short Interest in CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Drops By 99.9%

CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) was the recipient of a large decrease in short interest in February. As of February 15th, there was short interest totalling 100 shares, a decrease of 99.9% from the January 31st total of 89,100 shares. Based on an average daily trading volume, of 75,000 shares, the days-to-cover ratio is currently 0.0 days.

CNBX Pharmaceuticals Trading Down 15.6 %

OTCMKTS CNBX opened at $0.01 on Friday. The company has a 50 day moving average of $0.01 and a 200-day moving average of $0.01. CNBX Pharmaceuticals has a 1-year low of $0.01 and a 1-year high of $0.02.

About CNBX Pharmaceuticals

CNBX Pharmaceuticals Inc, a clinical stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome.